Histological Evaluation of Atrial Fibrillation Substrate Based on Atrial Septum Biopsy 2

Histological Evaluation of Atrial Fibrillation Substrate Based on Atrial Septum Biopsy 2 - HEAL-AF Study 2

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000044943

Enrollment

300

Registered

2021-07-26

Start date

2021-01-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Patients undergoing catheter ablation for atrial fibrillation between January 2021 and December 2022 2) Patients over 20 years old

Exclusion criteria

Exclusion criteria: 1) Patients who are pregnant or who may become pregnant 2) Patients with thrombus in the left atrium 3) Other patients who are judged by the attending physician to be unable to participate in the study

Design outcomes

Primary

Measure	Time frame
Relationship between histological findings based on atrial biopsy and outcomes at 3 years post-atrial fibrillation ablation	—

Secondary

Measure	Time frame
Histological evaluation of biopsy samples from the right atrium in patients with atrial fibrillation Relationship between histological and electrophysiological findings Relationship between histological findings and clinical factors Relationship between histological findings and gene expression	—

Countries

Japan

Contacts

Public ContactTAKANORI YAMAGUCHI

Saga University Hospital Department of Cardiovascular Medicine

takanori@cc.saga-u.ac.jp0952342443

Outcome results